Ipamorelin / CJC-1295 Rx
Pairs a selective growth-hormone secretagogue with a GHRH analog for a larger, longer pulse than either produces alone.
- Two complementary pathways
- Selective action
- Recovery and sleep
- Flexible monthly plans
- US-licensed pharmacies
- Clinician-guided dosing
- Pause or cancel anytime
Starting at$149 / mo
- HSA / FSA eligible
- Ongoing, expert support
- Free, discreet shipping
- 100% online
- Why combine two peptides?
- They act on different receptors that feed the same pituitary cells. Stimulating both produces a larger pulse than doubling either one.
- Will this raise my IGF-1 too much?
- That's precisely what the monitoring is for. We check IGF-1 at baseline and around twelve weeks, and reduce the dose if it climbs above the target range for your age.
- Sermorelin or this?
- Sermorelin is the gentler starting point. This combination is the step up for people who've tolerated sermorelin but want a stronger effect.
Injection-site reactions, flushing, head pressure shortly after dosing and water retention are the most commonly reported. Numbness or tingling in the hands usually signals the dose is too high.
Who this is not for
- Contraindicated with active malignancy
- Prohibited by WADA — relevant for tested athletes
- Requires IGF-1 monitoring; not a set-and-forget protocol
- Not evaluated in pregnancy or breastfeeding
Regulatory status: Compounded. Read our full medical disclaimer.
Disclaimer
Prescription products require an online evaluation with a licensed medical professional who will determine if a prescription is appropriate. This product is compounded by a licensed pharmacy. The FDA has not reviewed or approved compounded products for any use for safety, efficacy, or quality. Actual product packaging may appear differently than shown.
What is Ipamorelin / CJC-1295?
CJC-1295 is a modified GHRH analog with an extended half-life, sustaining the release signal to the pituitary for longer than native GHRH.
Ipamorelin is a selective growth-hormone secretagogue acting at the ghrelin receptor, a separate input to the same pituitary cells.
Individual results vary. Figures shown are modelled from published literature and aggregated, self-reported member check-ins; they are illustrative and are not a guarantee of outcome. See the evidence tier for this treatment.
days to a fair assessment
90How Ipamorelin / CJC-1295 works
Week 1
Onboarding, first dose and a check-in on tolerability. Most protocols start below the standard dose so your body has time to adjust.
30 Days
Your first real signal. We review side effects, adherence and any early changes before deciding whether to adjust anything.
3 Months
The window where most measurable change shows up. Repeat labs where the protocol calls for them, and a dose review either way.
6 Months
Trend lines rather than single readings. We compare against your baseline panel and decide whether to continue, adjust or stop.
1 Year and Beyond
Maintenance. The goal is the lowest effective dose you can hold, with twice-yearly labs keeping the protocol honest.
Our research is shaping what comes next
Most providers in this category focus on doing more. We study what happens when the goal is finding the right amount. With a fully in-house care team, longevity researchers, and 17+ protocols graded by evidence tier, we're built to support the bigger picture of your health.
Ipamorelin, a novel selective growth hormone secretagogue
European Journal of Endocrinology · 1998
CJC-1295 sustained GH and IGF-1 elevation in healthy adults
Journal of Clinical Endocrinology & Metabolism · 2006
Growth hormone secretagogues: mechanisms and clinical use
Endocrine Reviews · 2019
Ipamorelin / CJC-1295
treatment insights
Modelled response patterns are trending in the optimal range
Read our clinical trials
Growth hormone axis and longevity
Our researchers are studying ipamorelin / cjc-1295 through a longevity-focused lens, exploring how lower-dose protocols may be used in long-horizon care beyond the primary indication.
Read our researchSubscribe & save
Care that starts
with you
$149/month
What's included
- Personalized, clinician-guided plan
- Flexible monthly plans
- Dispensed by a US-licensed pharmacy
- Unlimited protocol adjustments and messaging
- Ongoing support and check-ins
- Pause or cancel anytime
- Third-party potency and sterility testing
How it works
Choosing how you age starts here
- Certified1
Clinician-led
Connect with a clinician
Connect with one of our US-licensed, in-house medical providers with 199+ years of combined clinical experience to make sure treatment is right for you. 100% online. No in-person visit required.
- 2
Fast, discreet shipping
Get your discreet shipment
If approved, your treatment is compounded by a US-licensed pharmacy, third-party tested by lot, and shipped to your door in unbranded packaging — cold-chain where the formulation requires it.
- 3
Ongoing support
Adjust as you go
Message your care team whenever something changes. Dose adjustments, side-effect questions and protocol changes are included in your membership — never another appointment, never another fee.
The protocol
- Typical dose
- 100–200 mcg of each, nightly
- Timing
- At bedtime, on an empty stomach
- Route
- Subcutaneous injection
- Cycling
- 8–12 weeks on, then a break
- Monitoring
- Baseline and 12-week IGF-1
A good fit if
- You've run sermorelin and want a stronger stimulus
- Recovery is the primary limiter on your training
- Body-composition goals on a multi-month horizon
- You'll commit to the monitoring schedule
Worth knowing
- Contraindicated with active malignancy
- Prohibited by WADA — relevant for tested athletes
- Requires IGF-1 monitoring; not a set-and-forget protocol
- Not evaluated in pregnancy or breastfeeding
Ready when you are
Start Ipamorelin / CJC-1295 today
Complete a ten-minute intake, get a licensed clinician's review, and find out whether this is right for you — before you pay for anything.